Application 040253
- Type
- ANDA
- Sponsor
- PHARM ASSOC
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | ETHOSUXIMIDE | ETHOSUXIMIDE | SYRUP;ORAL | 250MG/5ML | No | No |
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 0121-0670 | ETHOSUXIMIDE | ETHOSUXIMIDE | PAI Holdings, LLC | ANDA | Current |
| 0121-0670 | ETHOSUXIMIDE | ETHOSUXIMIDE | Pharmaceutical Associates, Inc. | ANDA | Current |
| 0121-0670 | ETHOSUXIMIDE | ETHOSUXIMIDE | Pharmaceutical Associates, Inc. | ANDA | Current |
| 0121-0670 | ETHOSUXIMIDE | ETHOSUXIMIDE | Pharmaceutical Associates, Inc. | ANDA | Current |